2020
DOI: 10.1007/978-3-030-41464-1_13
|View full text |Cite
|
Sign up to set email alerts
|

Theranostic Nanocarriers in Cancer: Dual Capabilities on a Single Platform

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(7 citation statements)
references
References 76 publications
0
7
0
Order By: Relevance
“…Biodegradable nanoparticles are needed in drug delivery to transport the drug and release it at the target site. 12 …”
Section: Application Of Nanotechnology For Cancer Diagnosis and Treat...mentioning
confidence: 99%
See 3 more Smart Citations
“…Biodegradable nanoparticles are needed in drug delivery to transport the drug and release it at the target site. 12 …”
Section: Application Of Nanotechnology For Cancer Diagnosis and Treat...mentioning
confidence: 99%
“…The fundamental knowledge required before selecting suitable carriers as a drug delivery system includes drug uptake and release, stability and shelf life of drug and carrier, biocompatibility, bio-distribution of the drug and carrier, and mode of action of the drug. 12 …”
Section: Application Of Nanotechnology For Cancer Diagnosis and Treat...mentioning
confidence: 99%
See 2 more Smart Citations
“…A few review articles have already presented the potential of various materials as theranostic carriers 1 , 5 , 18 , 19 . Wang et al presented an extended publication survey on the use of iron oxide NPs and derivative materials as theranostic agents 20 ; however, these agents were not described in the context of US theranostics.…”
Section: Introductionmentioning
confidence: 99%